International Clinical and Medical Case Reports Journal (ISSN: 2832-5788) | Volume 2, Issue 3 | Review Article | Open Access

A Review Article on Peripartum Cardiomyopathy

Adiba Fatima Samreen*

Fernandez Hospital, Hyderabad, Telangana, India

*Correspondence to: Adiba Fatima Samreen 

Fulltext PDF


Peripartum cardiomyopathy (PPCM) is an uncommon, dilated cardiomyopathy with left ventricular systolic failure that can occur during late pregnancy or within five months of delivery. Although the condition is widespread, it appears to be most prevalent in black, Nigerian, and Haiti women. Although the exact pathogenesis of peripartum cardiomyopathy is unknown, genetic, inflammatory, and pregnancy-related hemodynamic alterations are thought to be contributory causes. Typically, the patient presents with classic symptoms of heart failure, such as exertional dyspnea, lower extremity edema, and signs and symptoms of hypervolemia (such as rales, S3 gallop and edema). The risk of thromboembolism and tachyarrhythmias is increased with PPCM. Generally, echocardiography is diagnostic; in some circumstances, cardiac magnetic resonance may be required. Salt restriction, loop diuretics, and if blood pressure permits, cardio selective beta blockers may be used. Due to teratogenicity, angiotensin converting enzyme inhibitors, angiotensin receptor blockers, and mineralocorticoid receptor antagonists should be avoided. A multidisciplinary team strategy comprised of obstetricians, cardiologist, and maternal fetal medicine specialists should be adopted to enhance the outcome.


Peripartum cardiomyopathy; Hypervolemia; Thromboembolism; Tachyarrhythmias


Samreen AF.A Review Article on Peripartum Cardiomyopathy. Int Clinc Med Case Rep Jour. 2023;2(3):1-12.